Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1786 1
1910 2
1929 1
1948 1
1985 1
1988 1
1989 2
1990 5
1992 3
1993 1
1994 3
1995 7
1996 1
1997 2
1998 5
1999 3
2000 2
2001 3
2002 5
2003 1
2004 2
2005 3
2006 2
2007 2
2008 3
2009 5
2010 4
2011 8
2012 13
2013 11
2014 12
2015 22
2016 17
2017 22
2018 27
2019 31
2020 31
2021 31
2022 72
2023 31
2024 2

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26879784

378 results

Results by year

Filters applied: . Clear all
Page 1
[Quadruple regimens using domestically manufactured drugs in gastritis and duodenal ulcer patients for Helicobacter pylori eradication: a perspective, multicenter, randomized controlled trial].
Gao W, Hu F, Cheng H, Wang H, Yang Y, Liang H, Zhang S, Meng F, Cui M, Wei H, Sheng J, An HJ, Jiang B, Chen Y, Li Y, Zuo X, Gong J, Zhao P, Dong L, Wang B, Jiang K, Zhang G, Li J, Zhao Y, Gao H, Yang L. Gao W, et al. Zhonghua Yi Xue Za Zhi. 2016 Jan 26;96(4):260-4. doi: 10.3760/cma.j.issn.0376-2491.2016.04.006. Zhonghua Yi Xue Za Zhi. 2016. PMID: 26879784 Clinical Trial. Chinese.
[Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study].
Hu FL, Cheng H, Zhang XZ, An HJ, Sheng JQ, Lü NH, Xie Y, Chen ZS, Xu JM, Hu NZ, Zheng PY, Zhang L, Zhang LX, Zhang SS, Tao L, Zhang ZY, Cui MH, Yang GB, Wang BM, Jiang K, Yang Q, Gao HJ. Hu FL, et al. Zhonghua Yi Xue Za Zhi. 2012 Mar 13;92(10):679-84. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22781295 Clinical Trial. Chinese.
[Jinghuaweikang capsules combined with furazolidone-based triple or quadruple therapy as the rescue treatment for Helicobacter pylori infection: a multicenter randomized controlled clinical trial].
Cheng H, Hu FL, Sheng JQ, An HJ, Xu L, Liu FX, Li Y, Hao Q, Zheng PY, Lu GF, Cao ZQ, Wang YP. Cheng H, et al. Zhonghua Yi Xue Za Zhi. 2016 Nov 1;96(40):3206-3212. doi: 10.3760/cma.j.issn.0376-2491.2016.40.002. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27852385 Clinical Trial. Chinese.
Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
Xie Y, Zhu Z, Wang J, Zhang L, Zhang Z, Lu H, Zeng Z, Chen S, Liu D, Lv N; the Chinese Study Group on Helicobacter pylori, Chinese Society of Gastroenterology. Xie Y, et al. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00432-18. doi: 10.1128/AAC.00432-18. Print 2018 Sep. Antimicrob Agents Chemother. 2018. PMID: 29914954 Free PMC article. Clinical Trial.
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Salmanroghani H, Mirvakili M, Baghbanian M, Salmanroghani R, Sanati G, Yazdian P. Salmanroghani H, et al. PLoS One. 2018 Jun 11;13(6):e0197096. doi: 10.1371/journal.pone.0197096. eCollection 2018. PLoS One. 2018. PMID: 29889843 Free PMC article. Clinical Trial.
Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
Lee JY, Kim N, Park KS, Kim HJ, Park SM, Baik GH, Shim KN, Oh JH, Choi SC, Kim SE, Kim WH, Park SY, Kim GH, Lee BE, Jo Y, Hong SJ. Lee JY, et al. BMC Gastroenterol. 2016 Jul 26;16(1):79. doi: 10.1186/s12876-016-0490-8. BMC Gastroenterol. 2016. PMID: 27460100 Free PMC article. Clinical Trial.
Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y, Ford AC, Khan KJ, Gisbert JP, Forman D, Leontiadis GI, Tse F, Calvet X, Fallone C, Fischbach L, Oderda G, Bazzoli F, Moayyedi P. Yuan Y, et al. Cochrane Database Syst Rev. 2013 Dec 11;(12):CD008337. doi: 10.1002/14651858.CD008337.pub2. Cochrane Database Syst Rev. 2013. PMID: 24338763 Review.
378 results